Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
1999 1
2001 6
2002 1
2003 7
2004 5
2005 10
2006 7
2007 4
2008 4
2009 3
2010 4
2011 10
2012 5
2013 10
2014 3
2015 2
2016 4
2017 3
2018 2
2019 2
2020 1
2021 2
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.
Brenner E, Schörg BF, Ahmetlić F, Wieder T, Hilke FJ, Simon N, Schroeder C, Demidov G, Riedel T, Fehrenbacher B, Schaller M, Forschner A, Eigentler T, Niessner H, Sinnberg T, Böhm KS, Hömberg N, Braumüller H, Dauch D, Zwirner S, Zender L, Sonanini D, Geishauser A, Bauer J, Eichner M, Jarick KJ, Beilhack A, Biskup S, Döcker D, Schadendorf D, Quintanilla-Martinez L, Pichler BJ, Kneilling M, Mocikat R, Röcken M. Brenner E, et al. Nat Commun. 2020 Mar 12;11(1):1335. doi: 10.1038/s41467-020-14987-6. Nat Commun. 2020. PMID: 32165639 Free PMC article.
Cytokine-induced senescence (CIS) can stably arrest cancer cells, suggesting that interferon-dependent induction of senescence-inducing cell cycle regulators is needed to control those cancer cells that escape from killing. Here we report in two different cancers sensitive to …
Cytokine-induced senescence (CIS) can stably arrest cancer cells, suggesting that interferon-dependent induction of senescence-inducing cell …
Melanocytic nevi.
Hauschild A, Egberts F, Garbe C, Bauer J, Grabbe S, Hamm H, Kerl H, Reusch M, Rompel R, Schlaeger M; expert group "Melanocytic nevi". Hauschild A, et al. J Dtsch Dermatol Ges. 2011 Sep;9(9):723-34. doi: 10.1111/j.1610-0387.2011.07741.x. Epub 2011 Jul 15. J Dtsch Dermatol Ges. 2011. PMID: 21762380 English, German. No abstract available.
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.
Bilich T, Roerden M, Maringer Y, Nelde A, Heitmann JS, Dubbelaar ML, Peter A, Hörber S, Bauer J, Rieth J, Wacker M, Berner F, Flatz L, Held S, Brossart P, Märklin M, Wagner P, Erne E, Klein R, Rammensee HG, Salih HR, Walz JS. Bilich T, et al. Cancer Discov. 2021 Aug;11(8):1982-1995. doi: 10.1158/2159-8290.CD-21-0191. Epub 2021 May 19. Cancer Discov. 2021. PMID: 34011563
Unexposed patients with hematologic malignancies presented with reduced prevalence of preexisting SARS-CoV-2 cross-reactive CD4(+) T-cell responses and signs of T-cell exhaustion compared with patients with solid tumors and healthy volunteers. ...SIGNIFICANCE: This …
Unexposed patients with hematologic malignancies presented with reduced prevalence of preexisting SARS-CoV-2 cross-reactive CD4(+) T- …
Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up.
Gassenmaier M, Soltanpour N, Held L, Metzler G, Yazdi AS, Brecht IB, Schneider DT, Stadler R, Garbe C, Bauer J. Gassenmaier M, et al. Eur J Cancer. 2022 Mar;163:200-210. doi: 10.1016/j.ejca.2021.12.016. Epub 2022 Jan 31. Eur J Cancer. 2022. PMID: 35104769
Positive sentinel lymph node biopsies (6+/29) occurred at similar rates in all diagnostic groups (P = 0.83) and were not associated with an unfavourable outcome. ...
Positive sentinel lymph node biopsies (6+/29) occurred at similar rates in all diagnostic groups (P = 0.83) and were not associated w …
UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg Effect.
Kamenisch Y, Baban TSA, Schuller W, von Thaler AK, Sinnberg T, Metzler G, Bauer J, Schittek B, Garbe C, Rocken M, Berneburg M. Kamenisch Y, et al. J Invest Dermatol. 2016 Sep;136(9):1866-1875. doi: 10.1016/j.jid.2016.02.815. Epub 2016 May 13. J Invest Dermatol. 2016. PMID: 27185340 Free article. Review.
[Melanocytic nevi].
Hauschild A, Garbe C, Bauer J, Hamm H, Kerl H, Reusch M, Rompel R, Schlaeger M; weitere Mitglieder der Expertengruppe "melanozytäre Nävi". Hauschild A, et al. J Dtsch Dermatol Ges. 2006 Aug;4(8):686-97. doi: 10.1111/j.1610-0387.2006.05865.x. J Dtsch Dermatol Ges. 2006. PMID: 16895572 German. No abstract available.
T-helper-1-cell cytokines drive cancer into senescence.
Braumüller H, Wieder T, Brenner E, Aßmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, Ranta F, Ullrich S, Mocikat R, Braungart K, Mehra T, Fehrenbacher B, Berdel J, Niessner H, Meier F, van den Broek M, Häring HU, Handgretinger R, Quintanilla-Martinez L, Fend F, Pesic M, Bauer J, Zender L, Schaller M, Schulze-Osthoff K, Röcken M. Braumüller H, et al. Nature. 2013 Feb 21;494(7437):361-5. doi: 10.1038/nature11824. Epub 2013 Feb 3. Nature. 2013. PMID: 23376950 Free article.
However, efficient inhibition of exponential cancer growth by T cells and interferon-gamma (IFN-gamma) requires additional undefined mechanisms that arrest cancer cell proliferation. Here we show that the combined action of the T-helper-1-cell cytokines IFN-gamma an …
However, efficient inhibition of exponential cancer growth by T cells and interferon-gamma (IFN-gamma) requires additional undefined …
Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L, Eigentler TK, Meier F, Held M, Röcken M, Garbe C, Bauer J. Held L, et al. J Dtsch Dermatol Ges. 2011 Jul;9(7):510-6. doi: 10.1111/j.1610-0387.2011.07603.x. Epub 2011 Jan 19. J Dtsch Dermatol Ges. 2011. PMID: 21244632 Review. English, German.
Genetic and morphologic features for melanoma classification.
Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, Elder DE, McCarthy SW, Mihm MC, Schadendorf D, Scolyer RA, Spatz A, Bastian BC. Broekaert SM, et al. Pigment Cell Melanoma Res. 2010 Dec;23(6):763-70. doi: 10.1111/j.1755-148X.2010.00778.x. Pigment Cell Melanoma Res. 2010. PMID: 20874733 Free PMC article.
We confirmed that melanomas with BRAF mutations showed characteristic morphologic features (P < 0.0001) and metastasized more frequently to regional lymph nodes (P = 0.046). ...

We confirmed that melanomas with BRAF mutations showed characteristic morphologic features (P < 0.0001) and metastasized more freq

…
90 results